PierianDx
The new company, incorporated through a merger of the former Pierian, Seven Bridges, and UgenTec, has future ambitions in germline omics and CNS disorders.
Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform
Pierian, now a part of Velsera, is integrating Arima's gene fusion sequencing technology into its NGS analysis, interpretation, and reporting hub.
PierianDx Closes Equity Financing, Loan Facility for up to $47.5M
OrbiMed was the lead investor in the new financing, which is expected to drive PierianDx's commercial expansion. The firm raised $27 million in 2019.
Oct 28, 2019
PierianDx Raises $27M in Series B Round
Mar 12, 2019
Forensic Genomics Firm Othram Raises $4M
Feb 13, 2018
PierianDx Raises $3M in New Funding, Seeks $2M More
Nov 2, 2015
Nov 2, 2015